HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

Abstract
Several recent studies have established an association between abnormalities of complement factor H (FH) and the development of hemolytic uremic syndrome (HUS). To identify the relative importance of mutations in FH as a cause of HUS, we have undertaken mutation screening of the FH gene in 19 familial and 31 sporadic patients with FH. Mutations were found in two familial and three sporadic patients, and these clustered in exons 18-20, a domain important for host recognition. Moreover, this study demonstrates that familial HUS is likely to be a heterogeneous condition.
AuthorsA Richards, M R Buddles, R L Donne, B S Kaplan, E Kirk, M C Venning, C L Tielemans, J A Goodship, T H Goodship
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 68 Issue 2 Pg. 485-90 (Feb 2001) ISSN: 0002-9297 [Print] United States
PMID11170896 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CFH protein, human
  • Complement Factor H
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Binding Sites (genetics)
  • Complement Factor H (genetics)
  • Exons (genetics)
  • Frameshift Mutation
  • Hemolytic-Uremic Syndrome (genetics)
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Sequence Homology, Amino Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: